SAN DIEGO, Nov. 8, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (NasdaqGM:MNOV - News) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that it had withdrawn a proposed public offering of up to 6,000,000 shares of its common stock due to general stock market conditions and unusual trading activity in the Company’s stock.
